|
| The Roles of the TAM Receptor Family In Cancer |
| PROF. GIACCIA, Amato |
| University Of Oxford |
| Professor Amato Giaccia is an Emeritus Professor and the “Jack, Lulu, and Sam Willson Professor in Cancer Biology” at the Stanford University School of Medicine. He is also an Emeritus Professor at the University of Oxford, where he previously served as the Director of the Oxford Institute for Radiation Oncology. At Stanford, he was the Director of Basic Science at the Stanford Cancer Institute and led the Radiation Biology Program at Stanford’s Cancer Center.
Professor Giaccia's research focuses on the molecular mechanisms underlying tumor and normal tissue responses to hypoxia (low oxygen conditions). His contributions to the field have earned him international recognition, reflected in prestigious awards such as the ASTRO Gold Medal, NIH MERIT Award, Michael Fry Award from the Radiation Research Society, and the University of Pennsylvania’s John Yuhas Award for Excellence in Radiation Oncology.
He has published over 200 research articles in leading journals, including Nature, Cancer Cell, Molecular Cell, and PNAS, and co-authored the sixth, seventh, and eighth editions of the widely used textbook, Radiation Biology for the Radiologist, with Professor Eric Hall of Columbia University. His research has been continuously supported by major funding bodies such as the Medical Research Council (MRC), Cancer Research UK (CRUK), and the National Institutes of Health (NIH).
Beyond academia, Professor Giaccia has played a key role in translating scientific discoveries into clinical applications. He founded several biotechnology companies, including Arresto and Aravive, to develop targeted therapies against LOXL2 and AXL for cancer treatment.
|
|
|
